Legumain Antibodies

Santa Cruz Biotechnology features a diverse variety of Legumain monoclonal antibodies for research focused on understanding this important protein. Legumain Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Legumain, also known as asparaginyl endopeptidase, plays a crucial role in protein degradation and processing, particularly in antigen presentation and immune response. Its activity is significant in various physiological and pathological processes, including cancer progression and inflammation. Understanding Legumain function is essential for developing targeted therapies and advancing knowledge of immune regulation. Legumain research has revealed its importance in cellular processes and disease mechanisms. Recent studies have highlighted Legumain's potential as a therapeutic target in various pathological conditions. Ongoing research continues to uncover new functions and regulatory mechanisms of Legumain in health and disease. Santa Cruz Biotechnology monoclonal antibodies for Legumain research enable scientists worldwide to advance their understanding of immune system regulation and disease progression.